164 related articles for article (PubMed ID: 37008338)
21. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
22. [Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 5-year results of the TARGET Ⅱ trial].
Xu LJ; Gao Z; Song Y; Wang HH; Xu JJ; Gao LJ; Zhang Y; Song L; Zhao XY; Chen J; Yuan JQ; Qiao SB; Yang YJ; Xu B; Gao RL;
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jul; 46(7):523-528. PubMed ID: 30032542
[No Abstract] [Full Text] [Related]
23. Short- and long-term cardiovascular outcomes in insulin-treated versus non-insulin-treated diabetes mellitus patients after percutaneous coronary intervention: A systematic review and meta-analysis.
Hassan W; Saquib J; Khatri M; Kazmi SK; Kotak S; Hassan H; Ahmed J
Indian Heart J; 2022; 74(1):13-21. PubMed ID: 34906538
[TBL] [Abstract][Full Text] [Related]
24. Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials.
Bundhun PK; Qin T; Chen MH
BMC Cardiovasc Disord; 2015 Oct; 15():118. PubMed ID: 26450578
[TBL] [Abstract][Full Text] [Related]
25. The long-term clinical outcomes of intravascular ultrasound-guided versus angiography-guided coronary drug eluting stent implantation in long
Wang S; Liang C; Wang Y; Sun S; Wang Y; Suo M; Ye M; Li X; Liu X; Zhang M; Wu X
Front Cardiovasc Med; 2022; 9():944143. PubMed ID: 35990932
[TBL] [Abstract][Full Text] [Related]
26. Long time clinical outcomes of limus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary artery intervention: A meta-analysis of randomized controlled clinical trials.
Gao L; Hu X; Hou Y; Xue Q
Cardiol J; 2014; 21(3):211-9. PubMed ID: 24526500
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome.
Ma YL; Tang XF; Yao Y; Xu N; Song Y; Jiang P; Xu JJ; Wang HH; Jiang L; Liu R; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
Chin Med J (Engl); 2018 Jun; 131(12):1397-1405. PubMed ID: 29893356
[TBL] [Abstract][Full Text] [Related]
28. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
30. Incidence of coronary drug-eluting stent fracture: A systematic review and meta-analysis.
Chen Y; Li D; Liao Y; Yao X; Ruan Y; Zou K; Liao H; Ding J; Qin H; Yu Z; Zhao Y; Hu L; Yang R
Front Cardiovasc Med; 2022; 9():925912. PubMed ID: 36082117
[TBL] [Abstract][Full Text] [Related]
31. Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From the DUTCH PEERS (TWENTE II) Randomized Trial.
van Houwelingen KG; Lam MK; Löwik MM; Danse PW; Tjon Joe Gin RM; Jessurun GA; Anthonio RL; Sen H; Linssen GCM; IJzerman MJ; Doggen CJM; von Birgelen C
Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1152-1159. PubMed ID: 27595181
[TBL] [Abstract][Full Text] [Related]
32. Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies.
Guedeney P; Claessen BE; Mehran R; Kandzari DE; Aquino M; Davis S; Tamis L; Wang JC; Othman I; Gigliotti OS; Haghighat A; Singh S; Lopez M; Giugliano G; Horwitz PA; Sorrentino S; Underwood P; Allocco D; Meredith IT; Batchelor W
Catheter Cardiovasc Interv; 2019 Jul; 94(1):82-90. PubMed ID: 30666784
[TBL] [Abstract][Full Text] [Related]
33. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
Fanning JP; Nyong J; Scott IA; Aroney CN; Walters DL
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004815. PubMed ID: 27226069
[TBL] [Abstract][Full Text] [Related]
34. Stenting techniques for coronary bifurcation disease: a systematic review and network meta-analysis demonstrates superiority of double-kissing crush in complex lesions.
Wang R; Ding Y; Yang J; Wang K; Gao W; Fang Z; Zhou Y; Ge H
Clin Res Cardiol; 2022 Jul; 111(7):761-775. PubMed ID: 34862569
[TBL] [Abstract][Full Text] [Related]
35. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
36. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of intravascular imaging-guided drug-eluting stent implantation: a systematic review and meta-analysis of randomized clinical trials.
Niu Y; Bai N; Ma Y; Zhong PY; Shang YS; Wang ZL
BMC Cardiovasc Disord; 2022 Jul; 22(1):327. PubMed ID: 35870904
[TBL] [Abstract][Full Text] [Related]
38. Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
Siddiqi TJ; Khan MS; Karimi Galougahi K; Shlofmitz E; Moses JW; Rao S; West NEJ; Wolff E; Hochler J; Chau K; Khalique O; Shlofmitz RA; Jeremias A; Ali ZA
Catheter Cardiovasc Interv; 2022 Nov; 100 Suppl 1():S44-S56. PubMed ID: 36251325
[TBL] [Abstract][Full Text] [Related]
39. One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).
Tamburino C; Capodanno D; Erglis A; Menown IB; Horváth IG; Moreno R; Gilbert TJ; Crowley JJ; Calabria P; Allocco DJ; Dawkins KD
EuroIntervention; 2015 Mar; 10(11):1261-6. PubMed ID: 25572023
[TBL] [Abstract][Full Text] [Related]
40. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
